DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
As per enclsoed letter.14-08-2023
14-08-2023
Divi's Laboratories Results Earnings Call for Q1FY24
Conference Call with Divi's Laboratories Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.14-08-2023
Q1FY24 Quarterly Result Announced for Divi's Laboratories Ltd.
Pharmaceuticals company Divi's Laboratories announced Q1FY24 results: Total income of Rs 1,859 crore for Q1FY24 on a consolidated basis as against an income of Rs 2,343 crore for Q1FY23. Profit before Tax (PBT) for Q1FY24 amounted to Rs 492 crore as against a PBT of Rs 852 crore for Q1FY23 and a PBT of Rs 466 crore for Q4FY23. The Company earned a Profit after Tax (PAT) of Rs 356 crore for Q1FY24 as against a PAT of Rs 702 crore for Q1FY23. PAT for Q4FY23 was Rs 321 crore. Forex gain for Q1FY24 amounted to Rs 3 crore as against a gain of Rs 56 crore during Q1FY23. Result PDF14-08-2023
Divis Lab Share Price Live blog for 11 Aug 2023
Divis Lab stock price went up today, 11 Aug 2023, by 0.22 %. The stock closed at 3737.15 per share. The stock is currently trading at 3745.45 per share. Investors should monitor Divis Lab stock price closely in the coming days and weeks to see how it reacts to the news.11-08-2023
Divis Lab Share Price Live blog for 10 Aug 2023
Divis Lab stock price went down today, 10 Aug 2023, by -2.62 %. The stock closed at 3845.65 per share. The stock is currently trading at 3745 per share. Investors should monitor Divis Lab stock price closely in the coming days and weeks to see how it reacts to the news.10-08-2023
Divis Lab Share Price Live blog for 09 Aug 2023
Divis Lab stock price went down today, 09 Aug 2023, by -1.67 %. The stock closed at 3910.35 per share. The stock is currently trading at 3845 per share. Investors should monitor Divis Lab stock price closely in the coming days and weeks to see how it reacts to the news.09-08-2023
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the schedule of earnings conference call for the first quarter ended June 30, 2023 to be held on August 14, 2023.08-08-2023